Evidence map›Paper›PMID 36324521›Full record

ArticleFrontiers in chemistry2022

The antimicrobial peptide Magainin-2 interacts with BamA impairing folding of

Angela Di Somma, Carolina Cané, Antonio Moretta, Anna Illiano, Gabriella Pinto, Domenico Cavasso, Angela Amoresano, Luigi Paduano, Angela Duilio

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based onInternational journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela Di SommaDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Carolina CanéDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Antonio MorettaInstitut NeuroMyoGène, Unité Physiopathologie et Génétique du Neurone et du Muscle, CNRS UMR5261, INSERM U1315, Université Claude Bernard Lyon 1, Lyon, France.
Anna IllianoDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Gabriella PintoDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Domenico CavassoDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Angela AmoresanoDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Luigi PaduanoDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.
Angela DuilioDepartment of Chemical Sciences, University of Naples "Federico II", Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are a unique and diverse group of molecules endowed with a broad spectrum of antibiotics properties that are being considered as new alternative therapeutic agents. Most of these peptides are membrane-active molecules, killing bacteria by membrane disruption. However, recently an increasing number of AMPs was shown to enter bacterial cells and target intracellular processes fundamental for bacterial life. In this paper we investigated the mechanism of action of Maganin-2 (Mag-2), a well-known antimicrobial peptide isolated from the African clawed frog

Indexed as

antimicrobial peptidesmechanism of actionmembrane proteinsproteomicsstructural and functional characterization

Identifiers

PMID36324521
PMCPMC9620421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.